We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
-3.93%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$58.4M
AUM Growth
-$35.8M
Cap. Flow
-$33.5M
Cap. Flow %
-57.3%
Top 10 Hldgs %
41.11%
Holding
109
New
27
Increased
13
Reduced
25
Closed
40

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$2.5M
2
NXPI icon
NXP Semiconductors
NXPI
+$2.09M
3
WDC icon
Western Digital
WDC
+$1.49M
4
CI icon
Cigna
CI
+$1.16M
5
NVS icon
Novartis
NVS
+$962K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.44M
2
HUM icon
Humana
HUM
+$2.73M
3
BABA icon
Alibaba
BABA
+$2.34M
4
DIS icon
Walt Disney
DIS
+$1.74M
5
PYPL icon
PayPal
PYPL
+$1.72M

Sector Composition

Rank Sector Weight
1 Healthcare 49.52%
2 Technology 26.41%
3 Financials 2.04%
4 Communication Services 1.9%
5 Consumer Discretionary 1.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FICO icon
76
Fair Isaac
FICO
$22.5B
– –
-1,761
Closed -$553K
HUM icon
77
Humana
HUM
$46.2B
– –
-10,284
Closed -$2.73M
ICUI icon
78
ICU Medical
ICUI
$4.61B
– –
-4,990
Closed -$1.26M
INGN icon
79
Inogen
INGN
$164M
– –
-1,852
Closed -$124K
MMSI icon
80
Merit Medical Systems
MMSI
$5.32B
– –
-5,813
Closed -$346K
MSGS icon
81
Madison Square Garden
MSGS
$9.39B
– –
-4,474
Closed -$893K
NFLX icon
82
Netflix
NFLX
$309B
– –
-33,310
Closed -$1.22M
NYT icon
83
New York Times
NYT
$10.2B
– –
-36,859
Closed -$1.2M
OEF icon
84
PUT
iShares S&P 100 ETF
OEF
$20.6B
– –
-13,400
Closed -$575K
PCRX icon
85
Pacira BioSciences
PCRX
$997M
– –
-7,291
Closed -$317K
PFE icon
86
CALL
Pfizer
PFE
$153B
– –
-23,926
Closed -$983K
PFE icon
87
Pfizer
PFE
$153B
– –
-27,670
Closed -$1.14M
PGR icon
88
Progressive
PGR
$125B
– –
-20,617
Closed -$1.65M
PYPL icon
89
PayPal
PYPL
$50.5B
– –
-15,009
Closed -$1.72M
QCOM icon
90
CALL
Qualcomm
QCOM
$176B
– –
-46,200
Closed -$3.51M
QQQ icon
91
PUT
Invesco QQQ Trust
QQQ
$484B
– –
-73,100
Closed -$13.7M
RVTY icon
92
Revvity
RVTY
$12.8B
– –
-3,010
Closed -$290K
SE icon
93
Sea Limited
SE
$69.5B
– –
-34,270
Closed -$1.14M
SRPT icon
94
Sarepta Therapeutics
SRPT
$1.77B
– –
-6,730
Closed -$1.02M
TCOM icon
95
Trip.com Group
TCOM
$29.1B
– –
-28,959
Closed -$1.07M
THC icon
96
Tenet Healthcare
THC
$21.1B
– –
-19,048
Closed -$394K
TMO icon
97
Thermo Fisher Scientific
TMO
$220B
– –
-2,947
Closed -$865K
UNH icon
98
UnitedHealth
UNH
$370B
– –
-1,125
Closed -$275K
XNTK icon
99
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.23B
– –
-4,500
Closed -$395K
XYZ
100
Block Inc
XYZ
$47.5B
– –
-14,459
Closed -$1.05M
1 2 3
4
5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, Partner Investment Management held 109 positions worth $58.4M, down 38% from $94.2M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Partner Investment Management withdrew a net $33.5M in Q3 2019, closing 40 positions and reducing 25 holdings. Its most notable exit was Humana, an estimated $2.73M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 44% a quarter earlier, followed by Technology and Financials.

Against the trend, Partner Investment Management opened a new position in Alexion Pharmaceuticals worth $2.17M.

  • Partner Investment Management's largest Q3 2019 buy was Alexion Pharmaceuticals: 22,136 shares worth $2.17M.
  • Partner Investment Management added most to Twilio in Q3 2019, an estimated $926K increase.
  • Partner Investment Management's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $3.44M.
  • Partner Investment Management fully exited Humana in Q3 2019, selling an estimated $2.73M.
  • Partner Investment Management's ten largest holdings make up 41% of its $58.4M portfolio in Q3 2019.
  • Partner Investment Management opened 27 new positions and closed 40 in Q3 2019.
  • Partner Investment Management's portfolio value fell 38% quarter-over-quarter to $58.4M.

Based on Partner Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.